167 related articles for article (PubMed ID: 30643193)
1. Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.
Huang JJ; Corona AL; Dunn BP; Cai EM; Prakken JN; Blobe GC
Oncogene; 2019 May; 38(18):3402-3414. PubMed ID: 30643193
[TBL] [Abstract][Full Text] [Related]
2. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
[TBL] [Abstract][Full Text] [Related]
3. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
4. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
[TBL] [Abstract][Full Text] [Related]
5. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
6. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
[TBL] [Abstract][Full Text] [Related]
8. Role of TGF-β receptor III localization in polarity and breast cancer progression.
Meyer AE; Gatza CE; How T; Starr M; Nixon AB; Blobe GC
Mol Biol Cell; 2014 Aug; 25(15):2291-304. PubMed ID: 24870032
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
Criswell TL; Dumont N; Barnett JV; Arteaga CL
Cancer Res; 2008 Sep; 68(18):7304-12. PubMed ID: 18794117
[TBL] [Abstract][Full Text] [Related]
10. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
Finger EC; Turley RS; Dong M; How T; Fields TA; Blobe GC
Carcinogenesis; 2008 Mar; 29(3):528-35. PubMed ID: 18174241
[TBL] [Abstract][Full Text] [Related]
11. The type III TGF-beta receptor suppresses breast cancer progression.
Dong M; How T; Kirkbride KC; Gordon KJ; Lee JD; Hempel N; Kelly P; Moeller BJ; Marks JR; Blobe GC
J Clin Invest; 2007 Jan; 117(1):206-17. PubMed ID: 17160136
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
[TBL] [Abstract][Full Text] [Related]
14. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
Tazat K; Hector-Greene M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
[TBL] [Abstract][Full Text] [Related]
15. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
You HJ; How T; Blobe GC
Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
[TBL] [Abstract][Full Text] [Related]
16. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
Lee JD; Hempel N; Lee NY; Blobe GC
Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
[TBL] [Abstract][Full Text] [Related]
17. The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.
Lambert KE; Huang H; Mythreye K; Blobe GC
Mol Biol Cell; 2011 May; 22(9):1463-72. PubMed ID: 21411633
[TBL] [Abstract][Full Text] [Related]
18. Identification of soluble transforming growth factor-beta receptor III (sTbetaIII) in rat milk.
Zhang M; Zola H; Read L; Penttila I
Immunol Cell Biol; 2001 Jun; 79(3):291-7. PubMed ID: 11380683
[TBL] [Abstract][Full Text] [Related]
19. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
20. Roles for the type III TGF-beta receptor in human cancer.
Gatza CE; Oh SY; Blobe GC
Cell Signal; 2010 Aug; 22(8):1163-74. PubMed ID: 20153821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]